Sri Vidya Ramisetti

Ms. Sri Vidya Ramisetti

GITAM Deemed to be University, Visakhapatnam, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2023 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
SRSri Vidya Ramisetti
Sri Vidya Ramisetti
ANAKHILESHWAR NAMANI
AKHILESHWAR NAMANI
Genetic alterations in the NFE2L2 gene have been identified across various cancers, and the dysregulation of the NRF2 pathway due to these alterations leads to drug and radioresistance in several cancers. Identification of biomarkers associated with these alterations allows researchers and clinicians to provide personalized medicine and a quicker diagnosis. In this current study, we carried out an integrated, multi-omics, multi-database analysis of exome and transcriptomic data of NFE2L2-altered TCGA-Cervical squamous cell carcinoma (CSCC) patients against wild-type counterparts. Finally, we discovered the genes associated with NFE2L2 alterations and identified the prognostic genes which could be used as potential biomarkers in the NFE2L2-mutated CSCC patients. Our findings might be useful in the early diagnosis of NFE2L2-mutated CSCC patients.